Opko Health (OPK) Gains on FDA Nod

by Benzinga Staff

June 21, 2016 10:42 AM | 11 seconds read | Make a Comment

Opko Health Inc. (NYSE: OPK) shares rose 5.4% to $9.69 as the company reported that the FDA has approved NDA for RAYALDEE. Share volume was five million, compared to an all-day average of 3.7 million

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!